| 【Company Research】Henlius Biotech (2696 HK) – Promising Ph2 data of innovative assets |
| 【Company Research】iQIYI (IQ US) – Margin intact with continued ARM expansion |
| 【Company Research】Tongcheng Travel (780 HK) – Robust travel demand in FY24E |
| 【Company Research】Yili (600887 CH) - 4Q preview: rev/np reach RMB30.7bn/1.1bn |
| 【Company Research】Li Auto Inc. (LI US) – 4Q23 earnings preview: NP to be flat QoQ |
| 【Company Research】Horizon CD (9930 HK) – Sell-off unjustified; expect pressure to end in 2-3 days; BUY on price weakness |
| 【Sector Research】China Property Sector – NBS Dec data in line, still in bottoming process |
| 【Company Research】Baidu (BIDU US) – Ramp-up of generative AI-related revenue on track |
| 【Sector Research】China Internet – 2023 online retail sales recap and 2024 outlook |
| 【Company Research】WuXi Biologics (2269 HK) - On the road to recovery |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
